Anhui Wanbang Pharmaceutical Technology Co.,Ltd.

¥57.80As of Sun 8 Nov 2026, 12:00 UTC
SZSE:301520Healthcare
Country China
PE (Fwd) •••
TSR 3Y CAGR 3.43%
Div yield 0.37%
ROE 0.48%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.38
PE TTM 1,371
TSR TTM 90.24%
Mkt cap ¥5.362B
ROIC (2.80%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥63
9.05%
(74.23%)
Hold 2|3|12|5|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.93
0.88
0.91
0.98
(5.61%)
(10.78%)
(4.42%)
6.81%
Revenue¥M
491.6
494.6
521.7
540.3
12.43%
8.61%
10.32%
7.94%
Peers (US$803.8M)
Cap (US$)
PE
810.0M
57.58x
806.9M
112.9x
Capital
TTM
5Y
10Y
Leveragex
5.750
0.019
0.016
EBIT/Intx
1.407
0.941
0.875
Own earn%
70.18
(170.42)
(130.96)
Sh yield%
50.19
5.08
7.52
Owners
Insiders/Inst%
10.24
66.32
Short interest%
4.54
SBC / revenue%
3.88
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
25
Op margin range%
10–15
$1 testx
0.1
Incr. ROIC%
89